Literature DB >> 12496499

Atrial fibrillation in patients with heart failure.

B John Hynes1, Jerry C Luck, Deborah L Wolbrette, Luna Bhatta, Mazhar Khan, Soraya Samii, Gerald V Naccarelli.   

Abstract

Atrial fibrillation and heart failure are very common cardiac disorders, and both are associated with symptoms, significant morbidity, and mortality. Studies have attempted to determine the prognostic significance of atrial fibrillation in patients with heart failure. Whether atrial fibrillation is an independent risk factor of mortality remains controversial. Multiple trials using either pharmacologic or nonpharmacologic therapies in an attempt to manage atrial fibrillation have been developed. The purposes of this review are to present an overview of atrial fibrillation in patients with heart failure and to discuss the prevalence, prognostic significance, complications, mechanisms, and trials that have formed the therapies presently used.

Entities:  

Mesh:

Year:  2003        PMID: 12496499     DOI: 10.1097/00001573-200301000-00005

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  7 in total

1.  Is the E/V p index useful for evaluating prognosis in chronic heart failure with atrial fibrillation? A pilot study.

Authors:  Alejandro A Diaz; Edgardo M Rodríguez; Eduardo Escudero
Journal:  J Echocardiogr       Date:  2010-03-04

2.  Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction.

Authors:  James E Tisdale; Brian R Overholser; Heather A Wroblewski; Kevin M Sowinski; Kwadwo Amankwa; Steven Borzak; Joanna R Kingery; Rita Coram; Douglas P Zipes; David A Flockhart; Richard J Kovacs
Journal:  J Clin Pharmacol       Date:  2011-11-01       Impact factor: 3.126

3.  Importance of evaluating conduction block in radiofrequency ablation for atrial fibrillation.

Authors:  Borut Gersak; Andy C Kiser; Krzysztof Bartus; Jerzy Sadowski; Wolfgang Harringer; Michael Knaut; Gerhard Wimmer-Greinecker; Andrej Pernat
Journal:  Eur J Cardiothorac Surg       Date:  2012-01       Impact factor: 4.191

Review 4.  The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease.

Authors:  Xuexian Fang; Hossein Ardehali; Junxia Min; Fudi Wang
Journal:  Nat Rev Cardiol       Date:  2022-07-04       Impact factor: 49.421

Review 5.  Coenzyme Q10 in Cardiovascular and Metabolic Diseases: Current State of the Problem.

Authors:  Vladlena I Zozina; Serghei Covantev; Olga A Goroshko; Liudmila M Krasnykh; Vladimir G Kukes
Journal:  Curr Cardiol Rev       Date:  2018

6.  Arrhythmias and Electrocardiographic Changes in Systolic Heart Failure.

Authors:  Ashok Devkota; Ahmed Bakhit; Alix Dufresne; Aung Naing Oo; Premraj Parajuli; Saveena Manhas
Journal:  N Am J Med Sci       Date:  2016-04

Review 7.  Coenzyme Q10: Clinical Applications in Cardiovascular Diseases.

Authors:  Alma Martelli; Lara Testai; Alessandro Colletti; Arrigo F G Cicero
Journal:  Antioxidants (Basel)       Date:  2020-04-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.